• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

BiliSoft 2.0 Phototherapy System

A revolution in blue light phototherapy

 

phone-icon1800-102-2977

Bilisoft Hero
The BiliSoft™ 2.0 Phototherapy System helps provide family-centered care virtually anywhere—in the NICU, pediatrics units, well-baby nurseries, and even at home.

The right touch—and blue light—can make all the difference for infants with jaundice. GE Healthcare’s BiliSoft 2.0 Phototherapy System meets or exceeds the American Academy of Pediatrics (AAP) guidelines for intensive phototherapy to effectively treat hyperbilirubinemia and support even the tiniest patients with more comfort, better bonding, and higher quality developmental care.

Bilisoft Product

Patient & operational outcomes

Supporting family-centered care

 

Comfort can make all the difference

 

With BiliSoft 2.0, there’s no barrier to bonding between infant and parents or caregivers. The baby can be held, fed, even rocked throughout the therapy session, promoting a healing environment without interrupting the benefits of kangaroo care. With the benefits of kangaroo care well-documented, more hospitals are encouraging and supporting healthy, healing, “baby friendly” interactions and practices.

Bilisoft blue light phototherapy

The right light—right where it’s needed

 

Intensive therapy as easy as wrapping a blanket

 

BiliSoft 2.0 delivers phototherapy anywhere—in the neonatal ICU, pediatrics, well-baby nursery or at home. It can be used with a radiant warmer, incubator, bassinet, crib, or while in a caregiver’s arms. Additionally, the flat, cushioned BiliSoft 2.0 cover lets you swaddle the baby and phototherapy pad together.

The long-lasting, high–spectral–irradiance, blue LED light delivers healing phototherapy that meets and exceeds the recommendations of the AAP1. Positioning aids may also be placed under the pad to bring more light to the sides of a baby’s body for greater skin surface area exposure to the light.

Bilisoft Product With Pads

Fits just right

 

Conserve space and position as needed

 

Thanks to a small footprint and lightweight design, the BiliSoft 2.0 can be easily mounted to a bed or roll stand, providing added flexibility, space conservation in small care areas, and quicker access when the baby needs hands-on care. Plus, its long, flexible fiber-optic cable makes positioning easier and provides greater coverage than other fiber-optic devices and many overhead lamps. The pad design also helps to eliminate distance deficiencies.

Bilisoft Equiptment

Features

 

Units host a long-lasting blue LED light that provides more than 50,000 hours of light therapy

 

Long, lightweight fiber-optic cable and quiet operation makes BiliSoft 2.0 ideal for in-home use

 

Whisper-quiet operation helps maintain an environment to promote better sleep and growth

 

Babies can be wrapped in a blanket and even held during therapy for more comfort and relaxation

Resources

BiliSoft 2.0 brochure
BiliSoft 2.0 spec sheet
Footnotes
1. Bhutani, V and the Committee on the Fetus and Newborn, (2011). Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics, e1054.
Disclaimers

The official name of the product is Bilisoft 2.0 Phototherapy, authorized by Wipro GE HealthCare Pvt. Ltd., located at No 4, Kadugodi Industrial Area, Whitefield, Bangalore, Karnataka – 560067. The system is intended for use by trained healthcare professionals familiar with relevant clinical workflows and equipment operation. For safe and effective operation, users must verify system calibration, ensure correct supply and connectivity, and confirm settings appropriate to the patient’s clinical condition.


Continuous monitoring of patient vitals and system performance is essential throughout use. This system must not be used in environments containing explosive gases or on patients with contraindications to its intended clinical use. Operators must follow all institutional protocols, manufacturer instructions, and established clinical guidelines. This material was created and reviewed on 22nd December 2025, and additional product and safety information is available upon request.

Contact Us

We're ready to support you in your moments that matter. For service assistance, call us.

Thank you!

We received your request for assistance.

A GE Healthcare specialist will be reaching out shortly.

Something went wrong

We will check and get back.

JB01598IN March 2023